<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:ns="http://www.google.com/schemas/sitemap-pagemap/1.0" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.businesswire.com/news/home/20260328338918/en/EVTL-Investors-Have-Opportunity-to-Join-Vertical-Aerospace-Ltd.-Fraud-Investigation-with-the-Schall-Law-Firm</loc>
    <lastmod>2026-03-28T23:19:00.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>Business Wire</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:genres>PressRelease</news:genres>
      <news:publication_date>2026-03-28T23:19:00.000Z</news:publication_date>
      <news:title>EVTL Investors Have Opportunity to Join Vertical Aerospace Ltd. Fraud Investigation with the Schall Law Firm</news:title>
      <news:stock_tickers>EVTL</news:stock_tickers>
    </news:news>
    <ns:PageMap>
      <ns:DataObject type="thumbnail">
        <ns:Attribute name="name" value=""/>
        <ns:Attribute name="src" value="https://mms.businesswire.com/media/20260328338918/en/827144/21/Schall-Firm-Logo-640x360.jpg"/>
        <ns:Attribute name="width" value="150"/>
        <ns:Attribute name="height" value="150"/>
      </ns:DataObject>
    </ns:PageMap>
    <image:image>
      <image:loc>https://mms.businesswire.com/media/20260328338918/en/827144/21/Schall-Firm-Logo-640x360.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.businesswire.com/news/home/20260328721653/en/SAN-Investors-Have-Opportunity-to-Join-Banco-Santander-S.A.-Fraud-Investigation-with-the-Schall-Law-Firm</loc>
    <lastmod>2026-03-28T21:44:00.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>Business Wire</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:genres>PressRelease</news:genres>
      <news:publication_date>2026-03-28T21:44:00.000Z</news:publication_date>
      <news:title>SAN Investors Have Opportunity to Join Banco Santander, S.A. Fraud Investigation with the Schall Law Firm</news:title>
      <news:stock_tickers>SAN</news:stock_tickers>
    </news:news>
    <ns:PageMap>
      <ns:DataObject type="thumbnail">
        <ns:Attribute name="name" value=""/>
        <ns:Attribute name="src" value="https://mms.businesswire.com/media/20260328721653/en/827144/21/Schall-Firm-Logo-640x360.jpg"/>
        <ns:Attribute name="width" value="150"/>
        <ns:Attribute name="height" value="150"/>
      </ns:DataObject>
    </ns:PageMap>
    <image:image>
      <image:loc>https://mms.businesswire.com/media/20260328721653/en/827144/21/Schall-Firm-Logo-640x360.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.businesswire.com/news/home/20260328916391/en/BW-Investors-Have-Opportunity-to-Join-Babcock-Wilcox-Enterprises-Inc.-Fraud-Investigation-with-the-Schall-Law-Firm</loc>
    <lastmod>2026-03-28T21:21:00.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>Business Wire</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:genres>PressRelease</news:genres>
      <news:publication_date>2026-03-28T21:21:00.000Z</news:publication_date>
      <news:title>BW Investors Have Opportunity to Join Babcock &amp; Wilcox Enterprises, Inc. Fraud Investigation with the Schall Law Firm</news:title>
      <news:stock_tickers>BW</news:stock_tickers>
    </news:news>
    <ns:PageMap>
      <ns:DataObject type="thumbnail">
        <ns:Attribute name="name" value=""/>
        <ns:Attribute name="src" value="https://mms.businesswire.com/media/20260328916391/en/827144/21/Schall-Firm-Logo-640x360.jpg"/>
        <ns:Attribute name="width" value="150"/>
        <ns:Attribute name="height" value="150"/>
      </ns:DataObject>
    </ns:PageMap>
    <image:image>
      <image:loc>https://mms.businesswire.com/media/20260328916391/en/827144/21/Schall-Firm-Logo-640x360.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.businesswire.com/news/home/20260328084287/en/Kardigan-Announces-Positive-Phase-2-Data-for-Tonlamarsen-in-Patients-with-Uncontrolled-Hypertension-Presented-as-Late-Breaker-at-ACC.26-and-Simultaneously-Published-in-JACC</loc>
    <lastmod>2026-03-28T20:45:00.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>Business Wire</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:genres>PressRelease</news:genres>
      <news:publication_date>2026-03-28T20:45:00.000Z</news:publication_date>
      <news:title>Kardigan Announces Positive Phase 2 Data for Tonlamarsen in Patients with Uncontrolled Hypertension Presented as Late-Breaker at ACC.26 and Simultaneously Published in JACC</news:title>
    </news:news>
    <ns:PageMap>
      <ns:DataObject type="thumbnail">
        <ns:Attribute name="name" value=""/>
        <ns:Attribute name="src" value="https://mms.businesswire.com/media/20260328084287/en/2716871/21/Kardigan_Logo.jpg"/>
        <ns:Attribute name="width" value="150"/>
        <ns:Attribute name="height" value="150"/>
      </ns:DataObject>
    </ns:PageMap>
    <image:image>
      <image:loc>https://mms.businesswire.com/media/20260328084287/en/2716871/21/Kardigan_Logo.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.businesswire.com/news/home/20260328410580/en/Debevoise-Secures-Second-Circuit-Affirmance-of-Dismissal-of-%2416-billion-Claim-Against-YPF-S.A.</loc>
    <lastmod>2026-03-28T20:18:00.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>Business Wire</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:genres>PressRelease</news:genres>
      <news:publication_date>2026-03-28T20:18:00.000Z</news:publication_date>
      <news:title>Debevoise Secures Second Circuit Affirmance of Dismissal of $16 billion Claim Against YPF S.A.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.businesswire.com/news/home/20260328961027/en/YRD-Investors-Have-Opportunity-to-Join-Yiren-Digital-Ltd.-Fraud-Investigation-with-the-Schall-Law-Firm</loc>
    <lastmod>2026-03-28T19:47:00.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>Business Wire</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:genres>PressRelease</news:genres>
      <news:publication_date>2026-03-28T19:47:00.000Z</news:publication_date>
      <news:title>YRD Investors Have Opportunity to Join Yiren Digital Ltd. Fraud Investigation with the Schall Law Firm</news:title>
      <news:stock_tickers>YRD</news:stock_tickers>
    </news:news>
    <ns:PageMap>
      <ns:DataObject type="thumbnail">
        <ns:Attribute name="name" value=""/>
        <ns:Attribute name="src" value="https://mms.businesswire.com/media/20260328961027/en/827144/21/Schall-Firm-Logo-640x360.jpg"/>
        <ns:Attribute name="width" value="150"/>
        <ns:Attribute name="height" value="150"/>
      </ns:DataObject>
    </ns:PageMap>
    <image:image>
      <image:loc>https://mms.businesswire.com/media/20260328961027/en/827144/21/Schall-Firm-Logo-640x360.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.businesswire.com/news/home/20260328356604/en/PODD-Investors-Have-Opportunity-to-Join-Insulet-Corporation-Fraud-Investigation-with-the-Schall-Law-Firm</loc>
    <lastmod>2026-03-28T19:27:00.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>Business Wire</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:genres>PressRelease</news:genres>
      <news:publication_date>2026-03-28T19:27:00.000Z</news:publication_date>
      <news:title>PODD Investors Have Opportunity to Join Insulet Corporation Fraud Investigation with the Schall Law Firm</news:title>
      <news:stock_tickers>PODD</news:stock_tickers>
    </news:news>
    <ns:PageMap>
      <ns:DataObject type="thumbnail">
        <ns:Attribute name="name" value=""/>
        <ns:Attribute name="src" value="https://mms.businesswire.com/media/20260328356604/en/827144/21/Schall-Firm-Logo-640x360.jpg"/>
        <ns:Attribute name="width" value="150"/>
        <ns:Attribute name="height" value="150"/>
      </ns:DataObject>
    </ns:PageMap>
    <image:image>
      <image:loc>https://mms.businesswire.com/media/20260328356604/en/827144/21/Schall-Firm-Logo-640x360.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.businesswire.com/news/home/20260328305951/en/PRTH-Investors-Have-the-Opportunity-to-Join-Investigation-of-Priority-Technology-Holdings-Inc.-with-the-Schall-Law-Firm</loc>
    <lastmod>2026-03-28T19:02:00.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>Business Wire</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:genres>PressRelease</news:genres>
      <news:publication_date>2026-03-28T19:02:00.000Z</news:publication_date>
      <news:title>PRTH Investors Have the Opportunity to Join Investigation of Priority Technology Holdings, Inc. with the Schall Law Firm</news:title>
      <news:stock_tickers>PRTH</news:stock_tickers>
    </news:news>
    <ns:PageMap>
      <ns:DataObject type="thumbnail">
        <ns:Attribute name="name" value=""/>
        <ns:Attribute name="src" value="https://mms.businesswire.com/media/20260328305951/en/827144/21/Schall-Firm-Logo-640x360.jpg"/>
        <ns:Attribute name="width" value="150"/>
        <ns:Attribute name="height" value="150"/>
      </ns:DataObject>
    </ns:PageMap>
    <image:image>
      <image:loc>https://mms.businesswire.com/media/20260328305951/en/827144/21/Schall-Firm-Logo-640x360.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.businesswire.com/news/home/20260328441699/en/Incyte-Announces-New-Positive-54-Week-Late-Breaking-Data-for-Povorcitinib-in-Hidradenitis-Suppurativa-at-the-2026-American-Academy-of-Dermatology-AAD-Annual-Meeting</loc>
    <lastmod>2026-03-28T19:00:00.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>Business Wire</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:genres>PressRelease</news:genres>
      <news:publication_date>2026-03-28T19:00:00.000Z</news:publication_date>
      <news:title>Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting</news:title>
      <news:stock_tickers>INCY</news:stock_tickers>
    </news:news>
    <ns:PageMap>
      <ns:DataObject type="thumbnail">
        <ns:Attribute name="name" value=""/>
        <ns:Attribute name="src" value="https://mms.businesswire.com/media/20260328441699/en/1078784/21/Incyte_Color_Logo_JPEG_2colorpos.jpg"/>
        <ns:Attribute name="width" value="150"/>
        <ns:Attribute name="height" value="150"/>
      </ns:DataObject>
    </ns:PageMap>
    <image:image>
      <image:loc>https://mms.businesswire.com/media/20260328441699/en/1078784/21/Incyte_Color_Logo_JPEG_2colorpos.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.businesswire.com/news/home/20260328412417/ja</loc>
    <lastmod>2026-03-28T19:00:00.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>Business Wire</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:genres>PressRelease</news:genres>
      <news:publication_date>2026-03-28T19:00:00.000Z</news:publication_date>
      <news:title>1日1回投与の利便性を備えた経口薬であるザソシチニブによる、迅速かつ持続的な皮膚症状の改善効果および乾癬治療を変革する可能性を示唆した臨床試験結果の発表について</news:title>
      <news:stock_tickers>TAK,4502</news:stock_tickers>
    </news:news>
    <ns:PageMap>
      <ns:DataObject type="thumbnail">
        <ns:Attribute name="name" value=""/>
        <ns:Attribute name="src" value="https://mms.businesswire.com/media/20260328412417/ja/1876336/21/Takeda_Logo.jpg"/>
        <ns:Attribute name="width" value="150"/>
        <ns:Attribute name="height" value="150"/>
      </ns:DataObject>
    </ns:PageMap>
    <image:image>
      <image:loc>https://mms.businesswire.com/media/20260328412417/ja/1876336/21/Takeda_Logo.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.businesswire.com/news/home/20260328889059/en/Takedas-Zasocitinib-Delivered-Rapid-and-Durable-Skin-Clearance-in-a-Convenient-Once-Daily-Pill-Affirming-Promise-to-Reshape-Psoriasis-Care</loc>
    <lastmod>2026-03-28T19:00:00.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>Business Wire</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:genres>PressRelease</news:genres>
      <news:publication_date>2026-03-28T19:00:00.000Z</news:publication_date>
      <news:title>Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care</news:title>
      <news:stock_tickers>TAK,4502</news:stock_tickers>
    </news:news>
    <ns:PageMap>
      <ns:DataObject type="thumbnail">
        <ns:Attribute name="name" value=""/>
        <ns:Attribute name="src" value="https://mms.businesswire.com/media/20260328889059/en/1876336/21/Takeda_Logo.jpg"/>
        <ns:Attribute name="width" value="150"/>
        <ns:Attribute name="height" value="150"/>
      </ns:DataObject>
    </ns:PageMap>
    <image:image>
      <image:loc>https://mms.businesswire.com/media/20260328889059/en/1876336/21/Takeda_Logo.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.businesswire.com/news/home/20260328971109/en/Corcept-Presents-Data-from-MOMENTUM-Trial-at-American-College-of-Cardiology-Annual-Scientific-Session</loc>
    <lastmod>2026-03-28T18:45:00.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>Business Wire</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:genres>PressRelease</news:genres>
      <news:publication_date>2026-03-28T18:45:00.000Z</news:publication_date>
      <news:title>Corcept Presents Data from MOMENTUM Trial at American College of Cardiology Annual Scientific Session</news:title>
      <news:stock_tickers>CORT</news:stock_tickers>
    </news:news>
    <ns:PageMap>
      <ns:DataObject type="thumbnail">
        <ns:Attribute name="name" value=""/>
        <ns:Attribute name="src" value="https://mms.businesswire.com/media/20260328971109/en/2330117/21/Corcept_logo_new_black.jpg"/>
        <ns:Attribute name="width" value="150"/>
        <ns:Attribute name="height" value="150"/>
      </ns:DataObject>
    </ns:PageMap>
    <image:image>
      <image:loc>https://mms.businesswire.com/media/20260328971109/en/2330117/21/Corcept_logo_new_black.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.businesswire.com/news/home/20260328320362/en/AAD-2026-Late-Breaking-Nemolizumab-Data-Demonstrate-Clinically-Meaningful-Benefits-for-Children-Aged-2-to-11-With-Moderate-to-Severe-Atopic-Dermatitis</loc>
    <lastmod>2026-03-28T15:00:00.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>Business Wire</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:genres>PressRelease</news:genres>
      <news:publication_date>2026-03-28T15:00:00.000Z</news:publication_date>
      <news:title>AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis</news:title>
      <news:stock_tickers>GALD</news:stock_tickers>
    </news:news>
    <ns:PageMap>
      <ns:DataObject type="thumbnail">
        <ns:Attribute name="name" value=""/>
        <ns:Attribute name="src" value="https://mms.businesswire.com/media/20260328320362/en/2759690/21/Lawrence_Eichenfield_Christophe_Piketty_16-9.jpg"/>
        <ns:Attribute name="width" value="150"/>
        <ns:Attribute name="height" value="150"/>
      </ns:DataObject>
    </ns:PageMap>
    <image:image>
      <image:loc>https://mms.businesswire.com/media/20260328320362/en/2759690/21/Lawrence_Eichenfield_Christophe_Piketty_16-9.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.businesswire.com/news/home/20260327181824/en/Anumana-Secures-FDA-Clearance-for-First-of-Its-Kind-ECG-AI-Algorithm-for-Early-Detection-of-Pulmonary-Hypertension</loc>
    <lastmod>2026-03-28T14:48:00.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>Business Wire</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:genres>PressRelease</news:genres>
      <news:publication_date>2026-03-28T14:48:00.000Z</news:publication_date>
      <news:title>Anumana Secures FDA Clearance for First-of-Its-Kind ECG-AI Algorithm for Early Detection of Pulmonary Hypertension</news:title>
    </news:news>
    <ns:PageMap>
      <ns:DataObject type="thumbnail">
        <ns:Attribute name="name" value=""/>
        <ns:Attribute name="src" value="https://mms.businesswire.com/media/20260327181824/en/2759710/21/Anumana.jpg"/>
        <ns:Attribute name="width" value="150"/>
        <ns:Attribute name="height" value="150"/>
      </ns:DataObject>
    </ns:PageMap>
    <image:image>
      <image:loc>https://mms.businesswire.com/media/20260327181824/en/2759710/21/Anumana.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.businesswire.com/news/home/20260328205340/en/Arrowhead-Pharmaceuticals-Presents-New-Long-Term-Efficacy-and-Safety-Data-for-Plozasiran-Across-a-Spectrum-of-Hypertriglyceridemia-at-the-American-College-of-Cardiologys-75th-Annual-Scientific-Session-and-Expo</loc>
    <lastmod>2026-03-28T14:30:00.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>Business Wire</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:genres>PressRelease</news:genres>
      <news:publication_date>2026-03-28T14:30:00.000Z</news:publication_date>
      <news:title>Arrowhead Pharmaceuticals Presents New Long-Term Efficacy and Safety Data for Plozasiran Across a Spectrum of Hypertriglyceridemia at the American College of Cardiology’s 75th Annual Scientific Session and Expo</news:title>
      <news:stock_tickers>ARWR</news:stock_tickers>
    </news:news>
    <ns:PageMap>
      <ns:DataObject type="thumbnail">
        <ns:Attribute name="name" value=""/>
        <ns:Attribute name="src" value="https://mms.businesswire.com/media/20260328205340/en/523535/21/ah_logo_cmyk.jpg"/>
        <ns:Attribute name="width" value="150"/>
        <ns:Attribute name="height" value="150"/>
      </ns:DataObject>
    </ns:PageMap>
    <image:image>
      <image:loc>https://mms.businesswire.com/media/20260328205340/en/523535/21/ah_logo_cmyk.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.businesswire.com/news/home/20260328508442/en/IBRX-INVESTOR-ALERT-Robbins-Geller-Rudman-Dowd-LLP-Announces-that-ImmunityBio-Inc.-Investors-with-Substantial-Losses-Have-Opportunity-to-Lead-Class-Action-Lawsuit</loc>
    <lastmod>2026-03-28T14:15:00.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>Business Wire</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:genres>PressRelease</news:genres>
      <news:publication_date>2026-03-28T14:15:00.000Z</news:publication_date>
      <news:title>IBRX INVESTOR ALERT: Robbins Geller Rudman &amp; Dowd LLP Announces that ImmunityBio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit</news:title>
      <news:stock_tickers>IBRX</news:stock_tickers>
    </news:news>
    <ns:PageMap>
      <ns:DataObject type="thumbnail">
        <ns:Attribute name="name" value=""/>
        <ns:Attribute name="src" value="https://mms.businesswire.com/media/20260328508442/en/2313484/21/RGRD_Logo_2v2.jpg"/>
        <ns:Attribute name="width" value="150"/>
        <ns:Attribute name="height" value="150"/>
      </ns:DataObject>
    </ns:PageMap>
    <image:image>
      <image:loc>https://mms.businesswire.com/media/20260328508442/en/2313484/21/RGRD_Logo_2v2.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.businesswire.com/news/home/20260328341048/en/Visa-Street-Soccer-USA-and-Bank-of-America-to-Bring-Visa-Street-Soccer-Parks-to-Every-FIFA-World-Cup-2026-Host-City-in-the-U.S.</loc>
    <lastmod>2026-03-28T11:00:00.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>Business Wire</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:genres>PressRelease</news:genres>
      <news:publication_date>2026-03-28T11:00:00.000Z</news:publication_date>
      <news:title>Visa, Street Soccer USA and Bank of America to Bring Visa Street Soccer Parks to Every FIFA World Cup 2026™ Host City in the U.S.</news:title>
      <news:stock_tickers>V,BAC</news:stock_tickers>
    </news:news>
    <ns:PageMap>
      <ns:DataObject type="thumbnail">
        <ns:Attribute name="name" value=""/>
        <ns:Attribute name="src" value="https://mms.businesswire.com/media/20260328341048/en/2759497/21/Kids_A.jpg"/>
        <ns:Attribute name="width" value="150"/>
        <ns:Attribute name="height" value="150"/>
      </ns:DataObject>
    </ns:PageMap>
    <image:image>
      <image:loc>https://mms.businesswire.com/media/20260328341048/en/2759497/21/Kids_A.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.businesswire.com/news/home/20260326860298/en/Open-Label-Outpatient-Switch-Study-Demonstrates-Symptom-Stability-During-Transition-from-Oral-Atypical-Antipsychotics-to-Cobenfy-xanomeline-and-trospium-chloride</loc>
    <lastmod>2026-03-28T11:00:00.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>Business Wire</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:genres>PressRelease</news:genres>
      <news:publication_date>2026-03-28T11:00:00.000Z</news:publication_date>
      <news:title>Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition from Oral Atypical Antipsychotics to Cobenfy™ (xanomeline and trospium chloride)</news:title>
      <news:stock_tickers>BMY</news:stock_tickers>
    </news:news>
    <ns:PageMap>
      <ns:DataObject type="thumbnail">
        <ns:Attribute name="name" value=""/>
        <ns:Attribute name="src" value="https://mms.businesswire.com/media/20260326860298/en/2041631/21/bms_logo_300_rgb_pos.jpg"/>
        <ns:Attribute name="width" value="150"/>
        <ns:Attribute name="height" value="150"/>
      </ns:DataObject>
    </ns:PageMap>
    <image:image>
      <image:loc>https://mms.businesswire.com/media/20260326860298/en/2041631/21/bms_logo_300_rgb_pos.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.businesswire.com/news/home/20260327014418/en/Nicklaus-Companies-LLC-Closes-Sale-of-Business-to-Jack-Nicklaus-Backed-20-Majors-LLC</loc>
    <lastmod>2026-03-28T01:23:00.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>Business Wire</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:genres>PressRelease</news:genres>
      <news:publication_date>2026-03-28T01:23:00.000Z</news:publication_date>
      <news:title>Nicklaus Companies LLC Closes Sale of Business to Jack Nicklaus-Backed 20 Majors, LLC</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.businesswire.com/news/home/20260327774630/zh-HK</loc>
    <lastmod>2026-03-28T00:37:00.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>Business Wire</news:name>
        <news:language>zh-HK</news:language>
      </news:publication>
      <news:genres>PressRelease</news:genres>
      <news:publication_date>2026-03-28T00:37:00.000Z</news:publication_date>
      <news:title>METC截止日期：Rosen Law Firm敦促損失超過10萬美元的Ramaco Resources, Inc. (NASDAQ: METC)股東與法律事務所聯絡以瞭解有關其合法權益的資訊</news:title>
      <news:stock_tickers>METC</news:stock_tickers>
    </news:news>
    <ns:PageMap>
      <ns:DataObject type="thumbnail">
        <ns:Attribute name="name" value=""/>
        <ns:Attribute name="src" value="https://mms.businesswire.com/media/20260327774630/zh-HK/1164042/21/July_30%2C_2021_-_ROSEN_LOGO.jpg"/>
        <ns:Attribute name="width" value="150"/>
        <ns:Attribute name="height" value="150"/>
      </ns:DataObject>
    </ns:PageMap>
    <image:image>
      <image:loc>https://mms.businesswire.com/media/20260327774630/zh-HK/1164042/21/July_30%2C_2021_-_ROSEN_LOGO.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.businesswire.com/news/home/20260327761376/zh-CN</loc>
    <lastmod>2026-03-28T00:36:00.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>Business Wire</news:name>
        <news:language>zh-CN</news:language>
      </news:publication>
      <news:genres>PressRelease</news:genres>
      <news:publication_date>2026-03-28T00:36:00.000Z</news:publication_date>
      <news:title>METC截止日期：Rosen Law Firm敦促损失超过10万美元的Ramaco Resources, Inc. (NASDAQ: METC)股东与律所联系以了解有关其合法权益的信息</news:title>
      <news:stock_tickers>METC</news:stock_tickers>
    </news:news>
    <ns:PageMap>
      <ns:DataObject type="thumbnail">
        <ns:Attribute name="name" value=""/>
        <ns:Attribute name="src" value="https://mms.businesswire.com/media/20260327761376/zh-CN/1164042/21/July_30%2C_2021_-_ROSEN_LOGO.jpg"/>
        <ns:Attribute name="width" value="150"/>
        <ns:Attribute name="height" value="150"/>
      </ns:DataObject>
    </ns:PageMap>
    <image:image>
      <image:loc>https://mms.businesswire.com/media/20260327761376/zh-CN/1164042/21/July_30%2C_2021_-_ROSEN_LOGO.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.businesswire.com/news/home/20260327189267/zh-HK</loc>
    <lastmod>2026-03-28T00:24:00.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>Business Wire</news:name>
        <news:language>zh-HK</news:language>
      </news:publication>
      <news:genres>PressRelease</news:genres>
      <news:publication_date>2026-03-28T00:24:00.000Z</news:publication_date>
      <news:title>PLUG截止日期：Rosen Law Firm敦促Plug Power Inc. (NASDAQ: PLUG)股東與法律事務所聯絡以瞭解有關其合法權益的資訊</news:title>
      <news:stock_tickers>PLUG</news:stock_tickers>
    </news:news>
    <ns:PageMap>
      <ns:DataObject type="thumbnail">
        <ns:Attribute name="name" value=""/>
        <ns:Attribute name="src" value="https://mms.businesswire.com/media/20260327189267/zh-HK/1164042/21/July_30%2C_2021_-_ROSEN_LOGO.jpg"/>
        <ns:Attribute name="width" value="150"/>
        <ns:Attribute name="height" value="150"/>
      </ns:DataObject>
    </ns:PageMap>
    <image:image>
      <image:loc>https://mms.businesswire.com/media/20260327189267/zh-HK/1164042/21/July_30%2C_2021_-_ROSEN_LOGO.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.businesswire.com/news/home/20260327807517/zh-CN</loc>
    <lastmod>2026-03-28T00:24:00.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>Business Wire</news:name>
        <news:language>zh-CN</news:language>
      </news:publication>
      <news:genres>PressRelease</news:genres>
      <news:publication_date>2026-03-28T00:24:00.000Z</news:publication_date>
      <news:title>PLUG截止日期：Rosen Law Firm敦促Plug Power Inc. (NASDAQ: PLUG)股东与律所联系以了解有关其合法权益的信息</news:title>
      <news:stock_tickers>PLUG</news:stock_tickers>
    </news:news>
    <ns:PageMap>
      <ns:DataObject type="thumbnail">
        <ns:Attribute name="name" value=""/>
        <ns:Attribute name="src" value="https://mms.businesswire.com/media/20260327807517/zh-CN/1164042/21/July_30%2C_2021_-_ROSEN_LOGO.jpg"/>
        <ns:Attribute name="width" value="150"/>
        <ns:Attribute name="height" value="150"/>
      </ns:DataObject>
    </ns:PageMap>
    <image:image>
      <image:loc>https://mms.businesswire.com/media/20260327807517/zh-CN/1164042/21/July_30%2C_2021_-_ROSEN_LOGO.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.businesswire.com/news/home/20260327492704/en/ADMA-BIOLOGICS-INC.-INVESTIGATION-Kirby-McInerney-LLP-Announces-Investigation-Into-Potential-Securities-Fraud</loc>
    <lastmod>2026-03-28T00:00:00.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>Business Wire</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:genres>PressRelease</news:genres>
      <news:publication_date>2026-03-28T00:00:00.000Z</news:publication_date>
      <news:title>ADMA BIOLOGICS, INC. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud</news:title>
      <news:stock_tickers>ADMA</news:stock_tickers>
    </news:news>
    <ns:PageMap>
      <ns:DataObject type="thumbnail">
        <ns:Attribute name="name" value=""/>
        <ns:Attribute name="src" value="https://mms.businesswire.com/media/20260327492704/en/774509/21/new_KM_logo.jpg"/>
        <ns:Attribute name="width" value="150"/>
        <ns:Attribute name="height" value="150"/>
      </ns:DataObject>
    </ns:PageMap>
    <image:image>
      <image:loc>https://mms.businesswire.com/media/20260327492704/en/774509/21/new_KM_logo.jpg</image:loc>
    </image:image>
  </url>
</urlset>